Arvidsson, Ida
Strandberg, Olof
Palmqvist, Sebastian
Stomrud, Erik
Cullen, Nicholas
Janelidze, Shorena
Tideman, Pontus
Heyden, Anders
Åström, Karl
Hansson, Oskar
Mattsson-Carlgren, Niklas
Funding for this research was provided by:
Lund University
Article History
Received: 6 November 2023
Accepted: 10 March 2024
First Online: 19 March 2024
Declarations
:
: The studies were approved by the Ethical Review Authority of Sweden and Region Skåne, and all participants gave written informed consent to participate.
: Not applicable.
: OH has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. SP has acquired research support (for the institution) from ki elements / ADDF. In the past 2 years, he has received consultancy/speaker fees from BioArtic, Biogen, Lilly, and Roche.